The accelerated approval for patients with HER2 (ERBB2)-mutated disease follows an approval last August for use after prior ...

Published findings suggest clinicians should avoid blanket abstinence and offer individualized, stigma-free guidance on sleep ...

A first-in-human trial shows the feasibility and safety of delivering placenta-derived stem cells during prenatal ...

GLP-1s sometimes cause unpleasant side effects that can lead to nonadherence and discontinuation, but some patients stay the ...

For Aliya Redd, a fourth-year medical student at the University of Florida (UF) College of Medicine, Gainesville, Florida, the reality of the match process is sinking in as the March 4 deadline for ...

About 1 in 5 patients with B-cell lymphoma treated with loncastuximab develop skin-related adverse events, particularly ...

Examining the proximal colon for 3 minutes or longer during screening colonoscopy may improve detection of flat adenomas.

A new AHA scientific statement warns that cardiovascular disease is rising fastest among younger women, with stroke rates in ...

Joint AASLD/IDSA practice recommendations reflect new data on prevention, treatment, and surveillance of chronic hepatitis B, ...

Walk-in appointments can reduce the time to pediatric dermatology visits for both atopic dermatitis and hidradenitis suppurativa and reduce ED visits for atopic dermatitis, a study finds.

An interim review finds discrimination, staffing gaps, and poor facilities continue to undermine NHS maternity care in England.

Bimekizumab yields clinically meaningful improvements in the severity of hidradenitis suppurativa over 48 weeks, shifting most patients to a mild disease, a pooled analysis of two trials shows.